A: bevacizumab fab light chain B: bevacizumab fab heavy chain D: DNA (5'-D(*GP*CP*GP*GP*TP*TP*GP*GP*TP*GP*GP*TP*AP*GP*TP*TP*AP*CP*GP*TP*TP*CP*GP*C)-3') E: bevacizumab fab light chain F: bevacizumab fab heavy chain G: DNA (5'-D(*GP*CP*GP*GP*TP*TP*GP*GP*TP*GP*GP*TP*AP*GP*TP*TP*AP*CP*GP*TP*TP*CP*GP*C)-3') hetero molecules
E: bevacizumab fab light chain F: bevacizumab fab heavy chain G: DNA (5'-D(*GP*CP*GP*GP*TP*TP*GP*GP*TP*GP*GP*TP*AP*GP*TP*TP*AP*CP*GP*TP*TP*CP*GP*C)-3') hetero molecules
A: bevacizumab fab light chain B: bevacizumab fab heavy chain D: DNA (5'-D(*GP*CP*GP*GP*TP*TP*GP*GP*TP*GP*GP*TP*AP*GP*TP*TP*AP*CP*GP*TP*TP*CP*GP*C)-3') hetero molecules
DNA (5'-D(*GP*CP*GP*GP*TP*TP*GP*GP*TP*GP*GP*TP*AP*GP*TP*TP*AP*CP*GP*TP*TP*CP*GP*C)-3')
Mass: 7463.784 Da / Num. of mol.: 2 / Source method: obtained synthetically / Details: DNA aptamer / Source: (synth.) synthetic construct (others)
-
Antibody , 2 types, 4 molecules AEBF
#1: Antibody
bevacizumabfablightchain
Mass: 23471.949 Da / Num. of mol.: 2 Source method: isolated from a genetically manipulated source Source: (gene. exp.) Homo sapiens (human) / Production host: Cricetulus griseus (Chinese hamster)
#2: Antibody
bevacizumabfabheavychain
Mass: 24890.764 Da / Num. of mol.: 2 Source method: isolated from a genetically manipulated source Source: (gene. exp.) Homo sapiens (human) / Production host: Cricetulus griseus (Chinese hamster)